Press release
MedAware Systems Launches Comprehensive Dementia / Alzheimer’s Disease Research Database
MedAware Systems, Inc. announced today it is launching the world’s most comprehensive database of human clinical trials data on Dementia / Alzheimer’s disease. The database currently contains over 5,000 studies on Dementia and related diseases with more than 30 million data points available for analysis. The Company continuously updates this database as new studies are published.MedAware Systems’ patent-pending software and process converts published clinical trials into the component data which can then be analyzed using standard statistical analytic techniques.
The database, as well as analytics, are available for licensing by Industry and researchers.
“For the first time, all of the raw data from human clinical trials in the area of Dementia are available in a single database”, says Founder and Chief Science Officer, Dr. Zung Vu Tran, a leading authority on bio-statistics. He adds “We have solved a myriad of problems in collecting, organizing, and standardizing this vast quantity of data. Companies and researchers will now have, at their fingertips, data from thousands of medical research studies on Alzheimer’s disease and other forms of dementia. This will save them years of effort in trying to collect, analyze and continuously update the available science in the field.”
ABOUT MEDAWARE SYSTEMS, INC.
MedAware Systems, Inc. disrupts the health informatics industry by forever changing the way Pharma and medical device companies, physicians, payers and consumers derive usable evidence from published clinical trials research. The Company’s Science of Health Informatics (SOHInfo™) is a Scientific-Data-as-a-Service (SDaaS™) that solves the problem of making the vast and chaotic body of human clinical trials research instantly available and indispensable for understanding the safety and efficacy of medical treatments and devices.
MedAware Systems, Inc.
3400 Industrial Ln. Suite 1B
Broomfield, CO 80020
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MedAware Systems Launches Comprehensive Dementia / Alzheimer’s Disease Research Database here
News-ID: 859513 • Views: …
More Releases from MedAware Systems, Inc.
MedAware Systems Adds Sentiment Tracking for Social Media Event Reports
MedAware Systems announced today that it has added a new Sentiment Tracking feature to its Social Media Event Monitoring application for Medical Devices. This new feature offers valuable signaling intelligence for post market surveillance and reporting for MDR and FDA filings. The feature utilizes the Company's Advanced Intelligence™ capabilities to provide deeper insight into reported events and other related posts on Social Media.
Events are identified for specific devices and…
MedAware Systems Expands Neuromodulation Device Regulatory Data Portal
MedAware Systems announced today a major expansion of Neuromodulation device data in its SOHInfo (www.sohinfo.com) customer portal. The portal is populated with reported data from registries, published literature, and social media for all registered devices for Spinal Cord Stimulation, Peripheral Nerve Stimulation, Ganglia Dorsal Root Stimulation, RF Ablation, Parkinson - Deep Brain Stimulation, Sacral Stimulation – Incontinence, and others. Global regulatory reported data is provided on all manufacturers’ products for…
MedAware Systems Launches AI-Powered Post Market Surveillance for Catheter Intro …
MedAware Systems announces that its Science of Health Informatics (SOHInfo) Post Market Surveillance Service for Catheter Introducer devices is now available.
SOHInfo monitors government regulatory adverse event databases, published literature, and social media to provide complete monitoring of the devices from all major manufacturers, including Steris Corporation, Sotera Health, Abbott, Cardinal Health, Merit Medical, Cordis Corporation, Terumo, Cook Medical, Teleflex, Medtronic, C.R. Bard, and others.
The surveillance system supports both…
MedAware Systems Adds Social Media to its Medical Device Surveillance Service
MedAware Systems’ Science of Health Informatics (SOHInfo) announces a major upgrade of its medical device surveillance service to include reporting on social media posts.
SOHInfo monitors government regulatory adverse event databases as well as relevant data from the published literature. It now includes social media surveillance to provide complete monitoring of clients’ products. The platform offers comprehensive visibility and active alerts across all three major platforms, LinkedIn, Facebook, and Twitter.…
More Releases for Dementia
Revolutionising Dementia Care: Psychology World and Dementia India Alliance Unve …
Revolutionising Dementia Care: Psychology World and Dementia India Alliance Unveil New Training Course
As India faces a growing dementia crisis, Psychology World and the Dementia India Alliance (DIA) have joined forces to launch a new Dementia Orientation Certificate Course designed specifically for healthcare workers. The course, introduced on World Mental Health Day, aims to address the dual challenges of providing quality care for dementia patients and supporting the mental health of…
Empowering Growth: Dementia Diagnosis App Market 2024 and Industry Segments Expl …
Growing Demand of the Dementia Diagnosis App Market Overview 2024-2032:
The latest release from Infinity Business Insights titled Dementia Diagnosis App Market Research Report 2024-2032 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the Dementia Diagnosis App including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles, and strategies. Global Dementia Diagnosis App Market study with 100+ market data…
Frontotemporal Dementia Treatment Market - Empathy in Action: Pioneering Frontot …
Newark, New Castle, USA: The "Frontotemporal Dementia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Frontotemporal Dementia Treatment Market: https://www.growthplusreports.com/report/frontotemporal-dementia-treatment-market/8569
This latest report researches the industry structure,…
Dementia Care APP Market Analysis 2023 Global Future Outlook 2028, Key Applicati …
Dementia Care APP Market is segmented by Type, by region, by profile, and by Application. This Report holds market analysis, growth, slopes, forecast, and complete strategies in the future. It also guides with planned and organized choices that include the necessary information to perform PEST, SWOT, and STEER analysis. Moreover, the Dementia Care APP Market report analyses the vital performance and operational metrics so that you can plan robust business…
Dementia Care APP Market Is Booming Worldwide 2021-2027 | Dementia Digital Diary …
Global Dementia Care APP market 2020-2026 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Dementia Care APP market size, revenue, production, CAGR, consumption, profit margin, price, and different substantial factors. Whereas accentuation the key driving and Dementia Care APP restraining forces for this market, the report offers trends and developments. It additionally examines the role of the leading…
Dementia Treatment
Dementia Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
The global Dementia Drugs and Treatment market is valued at 13900 million US$ in 2018 is expected to reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025.
This report focuses on Dementia Drugs volume and value at global level, regional level and company level. From a global perspective, this…